Kocatürk, Emek; Deza Vargas, Luis Gustavo; Kızıltaç, Kübra; Giménez Arnau, Anna Maria
(Karger (S. Karger AG), 2018)
The recommended dose of omalizumab for the treatment of chronic spontaneous urticaria (CSU) is 300 mg every 4 weeks, but there is no recommendation for patients who do not benefit from this dose. Our aim is to present the ...